FDA Investigator: Geoffrey K. Kilili

- Geoffrey K. Kilili first started conducting FDA inspections in 2016, with the last inspection in 2024. Over that time, Geoffrey K. Kilili has conducted 80 inspections at 77 companies across 75 sites.

Get Geoffrey Kilili's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Avlon Industries, Inc, Melrose Park | 2024

Out-of-stock
Geoffrey K. Kilili
Human Drugs Form 483

FDA 483 RIO BIOFARMA BRASIL LTDA, Hortolandia | 2024

Out-of-stock
Geoffrey K. Kilili
Human Drugs Form 483

FDA 483 GOJO Industries Inc, Cuyahoga Falls | 2024

Out-of-stock
Geoffrey K. Kilili
Human Drugs Form 483

FDA 483 ISP Chemicals LLC, Columbus | 2024

Out-of-stock
Geoffrey K. Kilili
Animal Drugs & Feeds Form 483

FDA 483 Amgen, Inc., New Albany | 2023

Out-of-stock
Geoffrey K. Kilili
Human Drugs Form 483

FDA 483 Novartis Manufacturing LLC, Indianapolis | 2023

Out-of-stock
Geoffrey K. Kilili
Human Drugs Form 483

FDA 483 Safecor Health, LLC, Columbus | 2023

Out-of-stock
Geoffrey K. Kilili
Human Drugs Form 483

FDA 483 American Regent Inc., Hilliard | 2023

Out-of-stock
Geoffrey K. Kilili
Human Drugs Form 483

FDA 483 Stephen G. Kaler, M.D., Columbus | 2022

Out-of-stock
Geoffrey K. Kilili
Human Drug Form 483